ArticleTurkish journal of medical sciences2022

The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study.

Deniz Can Güven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.